Facebook
Twitter
LinkedIn
ForwardPerfecting Placement of PARPs: Preventing Progression of Ovarian Cancer On-Demand Webinar
In the fast paced world of PARP inhibitor approvals in both the setting of maintenance and therapy in ovarian cancer, this panel of experts will assist practitioners to understand how to order germline and somatic testing for BRCA and HRD mutations. Speakers discuss sequencing of PARP inhibitors as well as mitigating side effects. Additionally, they discuss future directions for the use of PARP inhibitors as well as briefly discuss resistance to PARP inhibitors.
Speakers:
Premal Thaker, MD, MS
Washington University in St. Louis Siteman Cancer Center
Mary (“Maggie”) Mullen, MD
Washington University in St. Louis School of Medicine
John Farley, MD, COL, FACOG, FACS
Dignity Health - Cancer Institute, St. Joseph's Hospital and Medical Center
Todd Tillmanns, MD, FACOG
West Cancer Center
Keywords: Ovarian, Ovary, PARP, PARPi, Maintenance therapy, Toxicity, future applications
This is an educational resource produced through collaboration between the Society of Gynecologic Oncology (SGO) and the Association of Community Cancer Centers (ACCC). 
This activity is supported by independent medical education grants from AstraZeneca and Merck.
Target Audience
Physicians, Trainees, Residents, Fellows, APPs
Additional Information
| Attachment | Size |
|---|---|
 Learner Notification | 75.4 KB |
Society of Gynecologic Oncology
2022 ACCC Series #2 - Perfecting Placement of PARPs: Preventing Progression of Ovarian Cancer
Enduring: July 27, 2022 - July 27, 2023
Online
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Society of Gynecologic Oncology (SGO). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians (ACCME) Credit Designation
Amedco LLC designates this enduring activity for a maximum of .50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of .50 ANCC contact hours.
Pharmacists and Pharmacy Technicians (ACPE) Credit Designation
Amedco LLC designates this activity for a maximum of .50 knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.
Available Credit
- 0.50 AMA PRA Category 1 Credit™
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Society of Gynecologic Oncology (SGO). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Amedco LLC designates this Enduring material for a maximum of 0.50 Enduring AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. - 0.50 AMA PRA Category 1 Credits™- For Non-physicians In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Society of Gynecologic Oncology (SGO). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PAs may claim a maximum of 0.50 Enduring Category 1 credits for completing this activity. - 0.50 CNE Contact Hours In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Society of Gynecologic Oncology (SGO). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Amedco LLC designates this activity for a maximum of 0.50 Enduring ANCC contact hours. - 0.50 Participation